ArticleJournal of translational medicine2026

Midkine as a novel prognostic and therapeutic target in meningioma: insights from single-cell analysis and organoid-based drug validation.

Pei-Ran Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.